Strategy
Should Your FQHC Launch Vision Care This Year? A 30-Minute Decision Walkthrough
Three of four FQHCs don't offer vision care. But the FQHCs running this 5-question walkthrough are deciding to launch — because the math works, the AI is FDA-cleared, and the federal advocacy window for fixing the workforce barriers is open. Walk the decision using the tools we built.
If you run an FQHC, you've probably never sat down with your CFO and said: 'Should we launch a vision service line?' Most FQHC executives haven't. The result: only 26% of US Community Health Centers offer vision services, and just 3% of CHC patients receive eye care annually (NACHC 2025). Yet the economics are unusually strong, the FDA-cleared AI for diabetic retinopathy pays better than human interpretation, and California's adult Medi-Cal vision benefit has been fully covered since January 2020. The CalMatters investigation in April 2026 made the kids' vision crisis impossible to ignore — only 16% of California Medi-Cal kids got an eye exam in 2022-24, down from 19% eight years earlier. This walkthrough takes 30 minutes. By the end, you'll have a defensible answer to whether your FQHC should launch vision care this year.
The 5 questions
Question 1
Does the math actually work for our FQHC?
Optometry visits qualify for the FULL FQHC PPS encounter rate in California. That's the line that decides whether vision is a charitable add-on or a strategic revenue line. At a conservative $300 PPS encounter, a single OD seeing 16 patients per day for 240 work days generates ~$1.08M in PPS revenue — and that's before you add a 40% dispensary capture rate.
Run YOUR numbers — not the generic ones. Open the Vision ROI Calculator and plug in your specific OD salary range, capital budget, expected encounter volume, and the actual PPS rate at your site. Many established CA FQHCs run $400+ per encounter; the calculator's $300 default is the floor. Sensitivity scenarios will show you the worst case ($250 PPS), conservative ($300), typical CA ($400), and Year 1 ramp (2,400 encounters before steady state).
If the line margin in your model is below $400K at your site's PPS rate and conservative volume, vision care may not be the right Year-1 service line for your FQHC. If it's above $700K, you have a defensible business case to bring to your board.
Use this tool
Vision ROI Calculator
7 input sliders, real-time computation, sensitivity scenarios, payback period. All defaults sourced from BLS, ACU 2023 FQHC survey, DHCS APM guide.
Question 2
Can we actually deploy AI diabetic retinopathy screening?
This is the question most FQHC executives have never asked. The answer surprises them. Three FDA-cleared autonomous AI systems are deployable today. Digital Diagnostics' LumineticsCore (formerly IDx-DR) was the FIRST FDA De Novo authorized autonomous AI in any field of medicine, cleared April 11, 2018. Eight years ago. Eyenuk's EyeArt followed in 2020 (broadest FDA detection scope — both more-than-mild AND vision-threatening DR). AEYE Health's AEYE-DS got 510(k) in 2022 and was expanded May 2024 for portable handheld via Optomed Aurora AEYE — the only FDA-cleared portable autonomous AI for DR.
CMS deliberately reimburses autonomous AI MORE than human interpretation. CPT 92229 (autonomous AI imaging) pays $43.67 in 2025. CPT 92228 (MD interpretation) pays $29.14. CPT 92227 (staff review) pays $17.35. The price differential is intentional policy: CMS uses reimbursement to drive AI adoption in primary care.
Cahaba Medical Care, an Alabama FQHC, deployed LumineticsCore. The result: AI identified diabetic retinopathy in MORE THAN 1-IN-4 patients screened that would otherwise have been missed. For your FQHC with a 1,000+ diabetic patient panel, that translates to ~250 patients with vision-threatening pathology surfaced. San Ysidro Health (San Diego CA FQHC) is currently running the most rigorous CA FQHC AI vision RCT — DRES-POCAI, 848 patients, EyeArt point-of-care AI, funded by Moore Foundation + Kaiser AIM-HI.
Use the AI Selection Wizard to walk through 4 questions (deployment model, FDA tenure preference, EHR, diabetic panel size) and get a recommendation tailored to your FQHC. Then explore the AI Tracker for FQHC-fit ratings on each vendor.
Use this tool
AI Selection Wizard
4-question decision tree → LumineticsCore vs EyeArt vs AEYE-DS recommendation with rationale, payback estimate, and vendor links.
Question 3
Can we recruit an OD without NHSC eligibility?
Here's the structural recruitment headwind no one talks about: optometrists are NOT eligible for NHSC Loan Repayment in FY2026. The HRSA NHSC FY2026 LRP guidance lists eligible disciplines — MD/DO, NP, PA, CNM, dental (DDS/DMD), dental hygienists, CRNAs, behavioral health providers. Optometry is excluded. Optometry was historically eligible but was removed; the AOA has been actively lobbying for restoration via the NHSC Improvement Act (HR 920 / S. 1445).
Recruitment data tells a more nuanced story. The ACU 2023 FQHC Optometry Workforce Survey found average FQHC OD salary of $155K nationally — but the rural premium is real: rural FQHC ODs earn $168K vs urban $151K. That reverses the conventional 'urban pays more' assumption. With CA Optometric Association membership, UC Berkeley / SCCO / Western alumni networks, and the CA AB 407 (2021) expanded scope advantage (anterior segment treatment, oral non-controlled non-glaucoma Rx, immunizations), CA FQHC OD recruitment is achievable — without NHSC.
Differentiators for FQHC OD recruitment: mission alignment (the LALES findings — 75% of LA Latinos with glaucoma were undiagnosed — hit different when you're working in the population that needs you most), FTCA coverage (peace of mind), AB 407 scope expansion (CA OD scope is among the broadest non-surgical scopes in the country, including immunization authority), and total compensation framing (benefits + retirement + bilingual differential where applicable).
And get loud about the federal policy fix. The NHSC Improvement Act (HR 920 / S. 1445) is in committee. AOA needs constituent voices pushing representatives. Push the policy fix from our advocacy tracker.
Use this tool
Advocacy: NHSC + Medi-Cal Rate
Two active vision advocacy actions: NHSC Improvement Act (HR 920 / S. 1445) for OD inclusion, plus Medi-Cal $47/exam rate update (unchanged 25 years).
Question 4
How do we source patients — and where do charity partners fit?
FQHCs that try to launch vision care without a patient sourcing plan are rebuilding the wheel. The pediatric pipeline is already built — you just have to MOU into it. Vision To Learn operates 9 mobile clinics in California, serving 800+ campuses statewide. They've done 55,000+ LAUSD eye exams + 44,000 glasses since 2017. Warby Parker Pupils Project (with Vision To Learn as CA partner) expanded to 75 California school districts in 2025 — the largest school-vision footprint in the state. They are NOT competition. They are your referral pipeline.
The school-FQHC handoff: school-based mobile clinics screen children + dispense simple refractive glasses. Children with strabismus, amblyopia, glaucoma suspicion, congenital eye disease, or systemic-disease eye complications need medical follow-up at an FQHC. Build the MOU before launch.
For adult care, VSP Eyes of Hope is the most operationally ready CA partner — they're headquartered in Rancho Cordova, have served 200,000+ Californians lifetime, and run mobile clinics. 2027 booking opens July 2026 (2026 may already be full). For surgical safety valve in the Bay Area, Lions Eye Foundation of CA-NV (711 Van Ness, SF) provides free comprehensive ophthalmic care including cataract surgery for uninsured patients. For Medicare-eligible 65+ uninsured patients, AAO EyeCare America's Senior Program gives free volunteer ophthalmologist exams.
Pediatric vision (EPSDT) is the secret economic weapon. Children under 21 on Medi-Cal get comprehensive eye exam plus glasses every 24 months with NO cost share, NO MCO sub-vendor friction, NO 24-month replacement limit if medically necessary. A pediatric vision program is operationally simpler than adult vision — and the pediatric → family conversion (a child's exam catches grandma's vision needs) is FQHC PPS gold.
Use this tool
Charity Partner Directory
9 vetted partners: VSP Eyes of Hope, Vision To Learn (75 CA districts), Warby Parker Pupils Project, OneSight, Lions Eye Foundation of CA-NV, InfantSEE, EyeCare America, VISION USA, Prevent Blindness.
Question 5
What's the 90-day operational plan?
If your answers to questions 1-4 are 'yes, the math works; yes, we can deploy AI; yes, we can recruit; yes, we have a sourcing plan' — the next question is operational. The Vision Service Line Launch Playbook breaks the 90 days into 3 phases × 12 weekly steps. Phase 1 (Days 1-30) is strategic foundation: capital sourcing, AI vendor selection, OD recruitment posting, MCO + charity partner outreach. Phase 2 (Days 31-60) is build out: equipment procurement, hiring, EHR templates, school MOU + ophthalmology referral agreements. Phase 3 (Days 61-90) is launch + scale: soft launch with first 25 patients, scale to 100 + activate school referral pipeline, Year 1 metrics dashboard + advocacy launch.
Each weekly step has a specific 4-item checklist with primary source links. The risk register identifies the 5 risks every FQHC vision launch hits: NHSC ineligibility recruitment friction, MCO sub-vendor billing complications, AI DR screening adoption gap, dispensary capture rate below benchmark, and pediatric pipeline conversion gap. Each comes with a specific mitigation strategy.
Year 1 targets: 3,000+ encounters at 60% capacity ramp, $900K+ PPS revenue, ≥70% HEDIS Eye Exam for Patients with Diabetes (EED) compliance, ≥40% dispensary capture rate. By Year 2, steady state: line margin near $700K, sustained quality measure improvement, established school partnership pipeline, and AI DR screening surfacing previously-missed pathology in 1-in-4 diabetic patients.
Use this tool
Vision Launch Playbook (90-day)
3 phases × 12 weekly steps with checklists. 4 milestones (Day 30/60/90/365). Risk register with mitigations. Embedded ROI calculator + AI wizard.
What's the cost of waiting?
Three of four FQHCs aren't even running this walkthrough. They're deferring the decision indefinitely. The cost of that deferral, in our view: each year a 5,000-diabetic-patient FQHC delays AI DR screening, ~250 cases of vision-threatening retinopathy go undetected. That's ~250 patients who walk into your primary care clinic for diabetes management and walk out with progressing eye disease no one caught. Many will eventually go blind. Some already have.
The economics work. The AI is FDA-cleared. The federal advocacy window for fixing the workforce barriers is open. CalMatters made the kids' vision crisis impossible to ignore in April 2026. The school-FQHC partnership pipeline is built — Vision To Learn covers 800+ campuses, Warby Parker Pupils Project covers 75 CA districts. The HRSA scope rule is clear (eyeglasses are not in scope, exam encounters bill at full PPS). The CA scope-of-practice rules are clear (AB 407 + SB 1406 give CA optometrists one of the broadest non-surgical scopes nationally).
The decision is yours. The tools are here. The 90-day playbook is ready. Go.
Every tool referenced above (and more)
The complete vision care toolkit on the FQHC Talent platform — interactive components, case studies, masterclass modules, workplace guides, research archive, OKR templates, advocacy actions, and supporting blog posts.
Full Vision Strategy Page
19 CA FQHC vision program inventory, scope-of-practice timeline (SB 1406 → AB 407 → SB 776), 15 disparity stats, salary benchmarks, 5 strategic gap FQHCs.
4 FQHC Vision Case Studies
Cahaba Medical Care AI deployment (1-in-4 detection), San Ysidro DRES-POCAI RCT (848 patients), FHCSD 5-clinic flagship, Alliance mobile vision van.
4 Vision Masterclasses
PPS Revenue Lever (35 min) · AI DR Screening Playbook (30 min) · Glaucoma Equity Strategy (25 min) · Kids' Vision Crisis Response (25 min).
6 Vision Workplace Guides
Launch Checklist, AI Implementation, Medi-Cal MCO Billing, School-FQHC MOU, Farmworker Vision, Glaucoma Screening Protocol.
11 Vision Research Archive Entries
LALES (2004), IDx-DR pivotal trial (2018), Cahaba implementation (2022), San Ysidro DRES-POCAI (2026), NACHC Brief, ACU Survey, SB 1406, AB 407.
Vision OKR Template
Featured: 'Launch Vision Service Line' — 6 KRs across hiring, capital deployment, AI DR screening, encounters/revenue target, charity partnerships, HEDIS EED. Downloadable Excel.
AI Tracker — Vision Vendors
Digital Diagnostics, Eyenuk, AEYE Health vendor cards with FQHC fit ratings, EHR integration matrix, NACHC partner status, FQHC customer references.
PPS Revenue Lever Blog Post
The strategic argument for vision care at FQHCs — why 3 of 4 FQHCs are leaving major money on the table.
FDA's First Medical AI Blog Post
8 years ago, IDx-DR became the first FDA-authorized autonomous AI in medicine. Why most FQHCs still don't have an AI fundus camera.
CA Kids' Vision Crisis Blog Post
Only 16% of California Medi-Cal kids got an eye exam — and 47 of 58 counties got worse. Why FQHCs are the only realistic capacity.
Primary Sources Cited
- · NACHC 2025 Vision Services Expansion Brief ($630M / 1,070 ODs / 10.7M unserved patients)
- · ACU 2023 FQHC Optometry Workforce Survey ($155K avg, $168K rural / $151K urban)
- · FDA De Novo IDx-DR Authorization (DEN180001)
- · Cahaba Medical Care AI Implementation White Paper (1-in-4 detection rate)
- · JAMA Network Open: San Ysidro DRES-POCAI Trial Protocol (NCT06721351)
- · CalMatters: 16% of Medi-Cal Kids Got an Eye Exam (April 2026)
- · NEI / LALES — Los Angeles Latino Eye Study (75% of Latinos with glaucoma undiagnosed)
- · HRSA NHSC FY2026 LRP Application Guidance (optometry NOT eligible)
- · CA SB 1406 (Aanestad, 2008) — OD Glaucoma Scope
- · CA AB 407 (Salas, 2021) — OD Anterior Segment + Oral Rx + Immunizations
- · HRSA BPHC Compliance FAQs (Section 330 eyewear exclusion)